as on November 1, 2025 at 1:29 am IST
Day's Low
Day's High
1.02%
Downside
3.06%
Upside
52 Week's Low
52 Week's High
43.32%
Downside
180.61%
Upside
Check Metavia Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$23.6M
EPS (TTM)
-1.1175
Dividend Yield
0.00%
PE Ratio (TTM)
0PEG Ratio
0Return On Equity TTM
-129.46%
Compare market cap, revenue, PE, and other key metrics of Metavia Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $23.6M | NA | NA | 0.00% | |
| BUY | $40.4B | 475.59% | -16.34 | -264.83% | |
| BUY | $59.4B | 270.85% | -505.15 | -12.96% | |
| BUY | $107.7B | 104.25% | 29.84 | 31.86% | |
| BUY | $68.7B | 19.91% | 15.67 | 32.13% |
Search interest for Metavia Inc Stock has decreased by -35% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 3 months, MTVA stock has moved up by 60.1%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 1009.8% return, outperforming this stock by 1108.1%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 184.3% return, outperforming this stock by 247.8%
| Organisation | Metavia Inc |
| Headquarters | 545 Concord Avenue, Cambridge, MA, United States, 02138 |
| CEO | Mr. Heon Kim Hyung |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. W. Christopher Fang M.D. | Consulting Chief Medical Officer & Advisor |
Mr. Michael C. Pine | Senior Vice President of Business Development Advisor |
Mr. Heon Kim Hyung | CEO, President & Director |
Mr. Marshall H. Woodworth | Chief Financial Officer |
Dr. Mi-Kyung Kim | Chief Scientific Officer |
Mr. Robert Homolka | Senior Vice President of Clinical Operations |
Metavia Inc share price today is $0.98 as on at the close of the market. Metavia Inc share today touched a day high of $1.01 and a low of $0.97.
Metavia Inc share touched a 52 week high of $2.75 on and a 52 week low of $0.56 on . Metavia Inc stock price today i.e. is closed at $0.98,which is 64.36% down from its 52 week high and 76.42% up from its 52 week low.
Metavia Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Metavia Inc (MTVA) shares with as little as ₹88.719 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹887.19 in Metavia Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Metavia Inc share’s latest price of $0.98 as on November 1, 2025 at 1:29 am IST, you will get 10.2041 shares of Metavia Inc. Learn more about
fractional shares .